Definium Therapeutics Inc. Common Shares vs State Street Corporation Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.97 (market cap $4.59B), while State Street Corporation Common Stock trades at $174.55 (market cap $48.10B). The key difference: State Street Corporation Common Stock is far larger — about 10.5× Definium Therapeutics Inc. Common Shares's market cap, and State Street Corporation Common Stock pays a 2.1% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and State Street Corporation Common Stock for 0 Days on average.
| DFTX | STT | |
|---|---|---|
Market Cap | $4.59B | $48.10B |
Volume | 2,103,937 | 2,033,865 |
Sector | Health | Financials |
52-Week High | $48.45 | $194.26 |
52-Week Low | $10.68 | $111.00 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $74.64B |
Dividend Yield | — | 2.1% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →State Street provides investment servicing, custody, and asset management services to institutional investors. Its asset management business includes the SPDR ETF range.
Read more on STT →